Robert Hawes Bartlett
CIK 1454496 · View on SEC EDGAR ↗
First SEC filing: Jan. 23, 2009 · Latest: Jan. 23, 2009
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2017 | CTSO | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 30, 2017 | CTSO | A | 16,000 | — | — | 16,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 7, 2016 | CTSO | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 7, 2016 | CTSO | A | 2,000 | — | — | 2,000 Direct | — | Acquired | (price as of 2026-08-21) |
| April 8, 2015 | CTSO | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-21) |
| April 8, 2015 | CTSO | A | 30,000 | — | — | 30,000 Direct | — | Acquired | (price as of 2026-08-21) |
| May 5, 2010 | CTSO | A | 900,000 | — | — | 1,125,000 Direct | +400.00% | Acquired | (price as of 2026-08-21) |
| Jan. 4, 2010 | CTSO | A | 175,000 | — | — | 225,000 Direct | +350.00% | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 24, 2017 | CTSO | Stock Option (right to buy) | Common Stock (20,000) | $5.60 | Feb. 24, 2017 | 20,000 | Acquired |
| Jan. 30, 2017 | CTSO | Stock Option (right to buy) | Common Stock (16,000) | $4.69 | June 7, 2026 | 16,000 | Acquired |
| June 7, 2016 | CTSO | Stock Option (right to buy) | Common Stock (20,000) | $4.69 | June 7, 2026 | 20,000 | Acquired |
| June 7, 2016 | CTSO | Stock Option (right to buy) | Common Stock (2,000) | $8.07 | April 8, 2025 | 2,000 | Acquired |
| April 8, 2015 | CTSO | Stock Option (right to buy) | Common Stock (20,000) | $8.07 | April 8, 2020 | 20,000 | Acquired |
| May 5, 2010 | CTSO | Stock Option | Common Stock (900,000) | $0.14 | May 5, 2020 | 900,000 | Acquired |
| Jan. 4, 2010 | CTSO | Stock Option | Common Stock (175,000) | $0.17 | Jan. 4, 2020 | 175,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 23, 2009 | CTSO | Common Stock Option [F1]→ Common Stock (50,000) | 50,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CTSO
MD Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | — | — | — | $6,646 | — | — | $54,000 | $60,646 |
| 2015 | — | $10,000 | — | $27,417 | — | — | $54,000 | $91,417 |
| 2014 | — | — | — | $6,000 | — | — | $53,000 | $59,000 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.